Targeting Therapy with Mitosomal Daunorubicin plus Amlodipine Has the Potential To Circumvent Intrinsic Resistant Breast Cancer
- 10 December 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 8 (1) , 162-175
Abstract
Intrinsic resistance of cancers is a major cause of failure in chemotherapy. We proposed here a strategy to overcome intrinsic resistance by constructing cancer cell mitochondria-specifically targeting drug-loaded liposomes, namely, mitosomal daunorubicin plus amlodipine. Anticancer agent daunorubicin and apoptotic inducer amlodipine were loaded together into the mitosomes, and targeting molecule dequalinium was modified on the surface. Evaluations were performed on the breast cancer MCF-7 and resistant MCF-7/adr cells and in animals. Mitosomal daunorubicin plus amlodipine were about 97 nm, selectively accumulated in mitochondria, induced the swelling and disruption of mitochondria, dissipated the mitochondrial membrane potential, released a large amount of cytochrome C by translocation, cleaved Bid, and initiated a cascade of caspase 8 and 3 reactions. A robust anticancer effect was evidenced in vivo. Mitochondria-specifically targeting drug-loaded liposomes would provide a new strategy for treating resistant cancers.Keywords
This publication has 40 references indexed in Scilit:
- Environment-Responsive Multifunctional Liposomes2009
- Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in ratsNuclear Medicine and Biology, 2009
- Mitochondrial membrane permeabilization in neuronal injuryNature Reviews Neuroscience, 2009
- Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticlesActa Biomaterialia, 2009
- Mitochondrial regulation of insect cell apoptosis: Evidence for permeability transition pore-independent cytochrome-c release in the Lepidopteran Sf9 cellsThe International Journal of Biochemistry & Cell Biology, 2009
- Bcl‐2 changes conformation to inhibit Bax oligomerizationThe EMBO Journal, 2006
- ApoptosisCell, 2002
- Collapse of the Inner Mitochondrial Transmembrane Potential Is Not Required for Apoptosis of HL60 CellsExperimental Cell Research, 1999
- Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicineLife Sciences, 1997
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995